KFC
Klingenstein Fields & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.45M | Buy |
16,099
+9,155
| +132% | +$4.81M | 0.33% | 66 |
|
2025
Q1 | $4.4M | Buy |
6,944
+138
| +2% | +$87.5K | 0.19% | 73 |
|
2024
Q4 | $4.85M | Buy |
6,806
+6,231
| +1,084% | +$4.44M | 0.2% | 73 |
|
2024
Q3 | $604K | Hold |
575
| – | – | 0.02% | 114 |
|
2024
Q2 | $604K | Hold |
575
| – | – | 0.03% | 112 |
|
2024
Q1 | $553K | Hold |
575
| – | – | 0.02% | 114 |
|
2023
Q4 | $505K | Sell |
575
-1
| -0.2% | -$878 | 0.02% | 116 |
|
2023
Q3 | $474K | Hold |
576
| – | – | 0.02% | 116 |
|
2023
Q2 | $414K | Buy |
576
+1
| +0.2% | +$719 | 0.02% | 118 |
|
2023
Q1 | $472K | Hold |
575
| – | – | 0.02% | 111 |
|
2022
Q4 | $415K | Hold |
575
| – | – | 0.02% | 126 |
|
2022
Q3 | $396K | Hold |
575
| – | – | 0.02% | 130 |
|
2022
Q2 | $340K | Hold |
575
| – | – | 0.02% | 134 |
|
2022
Q1 | $402K | Sell |
575
-225
| -28% | -$157K | 0.02% | 140 |
|
2021
Q4 | $505K | Sell |
800
-85
| -10% | -$53.7K | 0.02% | 131 |
|
2021
Q3 | $536K | Hold |
885
| – | – | 0.02% | 134 |
|
2021
Q2 | $494K | Hold |
885
| – | – | 0.02% | 141 |
|
2021
Q1 | $419K | Buy |
885
+375
| +74% | +$178K | 0.02% | 142 |
|
2020
Q4 | $246K | Buy |
+510
| New | +$246K | 0.01% | 162 |
|
2017
Q2 | – | Sell |
-1,940
| Closed | -$752K | – | 227 |
|
2017
Q1 | $752K | Buy |
1,940
+40
| +2% | +$15.5K | 0.03% | 140 |
|
2016
Q4 | $697K | Buy |
+1,900
| New | +$697K | 0.03% | 144 |
|